longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Inhibrx Biosciences

INBX

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI
  • Weekly Recap | Editas Medicine -16.41%, consensus target above spot

    Weekly Review·Sep 12 at 08:10 AM
    EDIT+3.04%
  • Weekly Recap | Caris Life Sciences -2.91%, most brokers rate it buy

    Weekly Review·Sep 12 at 07:49 AM
    CAI-1.02%
  • Weekly Recap | Abbvie +0.26%, most brokers rate it buy

    Weekly Review·Sep 12 at 07:40 AM
    ABBV-0.20%
  • Weekly Recap | Twist Bioscience +2%, consensus target below spot

    Weekly Review·Sep 12 at 07:00 AM
    TWST+3.60%
  • Weekly Recap | Sellas Life Sciences -16.7%, Friday's heavy-volume slide

    Weekly Review·Sep 12 at 06:47 AM
    SLS+3.28%
  • Weekly Recap | Revolution Medicines -2.98%, consensus target above spot

    Weekly Review·Sep 12 at 06:40 AM
    RVMD-4.36%